RRAGA — Ras-Related GTP Binding A

Migration, Crosslink

📖

RRAGA — Ras-Related GTP Binding A

active

wiki page Created: 2026-04-02T07:19:28 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-rraga

📖 Wiki Page

gene2350 wordssynced 2026-04-02

title: RRAGA — Ras-Related GTP Binding A
category: gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Ras-Related GTP Binding A (RagA)</th></tr>
<tr><td>Gene Symbol</td><td>RRAGA</td></tr>
<tr><td>Full Name</td><td>Ras-Related GTP Binding A</td></tr>
<tr><td>Aliases</td><td>RagA, RAGA, RRAGA</td></tr>
<tr><td>Chromosome</td><td>9p21.1</td></tr>
<tr><td>NCBI Gene ID</td><td>[10670](https://www.ncbi.nlm.nih.gov/gene/10670)</td></tr>
<tr><td>OMIM</td><td>608456</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000136996</td></tr>
<tr><td>UniProt ID</td><td>[Q9Y282](https://www.uniprot.org/uniprot/Q9Y282)</td></tr>
<tr><td>Protein Class</td><td>Small GTPase, Rag GTPase family</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Autophagy Disorders](/mechanisms/autophagy), Metabolic Disorders</td></tr>
</table>
</div>

Pathway / Interaction Diagram

...

title: RRAGA — Ras-Related GTP Binding A
category: gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Ras-Related GTP Binding A (RagA)</th></tr>
<tr><td>Gene Symbol</td><td>RRAGA</td></tr>
<tr><td>Full Name</td><td>Ras-Related GTP Binding A</td></tr>
<tr><td>Aliases</td><td>RagA, RAGA, RRAGA</td></tr>
<tr><td>Chromosome</td><td>9p21.1</td></tr>
<tr><td>NCBI Gene ID</td><td>[10670](https://www.ncbi.nlm.nih.gov/gene/10670)</td></tr>
<tr><td>OMIM</td><td>608456</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000136996</td></tr>
<tr><td>UniProt ID</td><td>[Q9Y282](https://www.uniprot.org/uniprot/Q9Y282)</td></tr>
<tr><td>Protein Class</td><td>Small GTPase, Rag GTPase family</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Autophagy Disorders](/mechanisms/autophagy), Metabolic Disorders</td></tr>
</table>
</div>

Pathway / Interaction Diagram

Mermaid diagram (expand to render)

Overview

RRAGA (Ras-Related GTP Binding A), also known as RagA, is a member of the Rag GTPase family that plays a central role in regulating the [mTORC1 (mechanistic target of rapamycin complex 1) signaling pathway](/proteins/mtorc1-protein)[1]. Located on chromosome 9p21.1, this gene encodes a prote[@choi2020]in that functions as a molecular switch, cycling between active GTP-bound and inactive GDP-bound states to control nutrient sensing and cellular growth[2].

RagA forms obligate heterodimers with RagC (or its paralog RagD) to create the Rag GTPases, which sense amino acid availability and regulate mTORC1 localization and activation[3]. This pathway is fundamental to cellular homeostasis, controlling [protein synthesis](/mechanisms/protein-synthesis-neruodegeneration), [autophagy](/mechanisms/autophagy), cell growth, and metabolism. In the nervous system, RagA-mediated mTORC1 signaling regulates [synaptic plasticity](/mechanisms/synaptic-plasticity), neuronal survival, and [protein quality control](/mechanisms/protein-quality-control)[4].

Dysregulation of the RagA-mTORC1 axis has been implicated in the pathogenesis of neurodegenerative diseases including [Alzheimer's disease (AD)](/diseases/alzheimers-disease) and [Parkinson's disease (PD)](/diseases/parkinsons-disease)[5][6]. Mutations in RRAGA and related genes have been associated with neurodegenerative disorders, highlighting the importance of this pathway in neuronal health.

Molecular Biology and Structure

Protein Structure and Domains

RagA is a small GTPase belonging to the Ras superfamily. The protein contains:

GxxxxGKST motif: Phosphate-binding loop (P-loop) for nucleotide binding
NKXD motif: Specific to GTPases, involved in GDP/GTP binding
Switch I region: Undergoes conformational changes between GDP/GTP states
Switch II region: Critical for effector interactions
C-terminal region: Mediates dimerization with RagC/D

Nucleotide Cycling

Like other GTPases, RagA functions as a molecular switch:

Active state (GTP-bound): Recruits mTORC1 to lysosomal membranes
Inactive state (GDP-bound): Releases mTORC1 into the cytoplasm

The nucleotide state is regulated by:

GATOR1 complex: GAP (GTPase-activating protein) that promotes RagA GTP hydrolysis (inactivating)
Ragulator complex: GEF (Guanine nucleotide exchange factor) that promotes RagA-GTP loading (activating)

Function in the Brain

mTORC1 Regulation in Neurons

In [neurons](/entities/neurons), RagA-mediated mTORC1 signaling is critical for activity-dependent translational regulation[7]. When amino acids are abundant, RagA is in the active GTP-bound state and recruits mTORC1 to the lysosomal surface, where it can be activated by Rheb. This activation drives:

Local protein synthesis at synapses
Synaptic plasticity and memory formation
Neuronal growth and development
Metabolic regulation

RagA-mTORC1 signaling integrates multiple signals including amino acids, growth factors, and energy status to coordinate neuronal responses to changing conditions.

Autophagy Regulation

RagA plays a dual role in [autophagy](/mechanisms/autophagy) regulation[8]. When nutrients are abundant (RagA-GTP), mTORC1 is active and phosphorylates ULK1 complex, inhibiting autophagy initiation. During nutrient starvation (RagA-GDP), mTORC1 is released, ULK1 is activated, and autophagy is induced to recycle cellular components.

This regulation is particularly important in neurons due to their post-mitotic nature and high metabolic demands. Impaired autophagy leads to accumulation of protein aggregates and damaged organelles, both hallmarks of neurodegeneration.

Synaptic Function

RagA-mediated signaling regulates synaptic plasticity through control of local protein synthesis at dendritic spines[9]. Activity-dependent translation is essential for long-term potentiation (LTP) and memory formation. Dysregulation of this pathway contributes to synaptic dysfunction in AD and other neurodegenerative diseases.

Lysosomal Function

As a regulator of mTORC1 localization to lysosomes, RagA is intimately connected to [lysosomal function](/mechanisms/lysosomal-dysfunction)[10]. Lysosomes serve as nutrient sensors and sites of autophagic degradation. RagA ensures proper coordination between lysosomal nutrient sensing and mTORC1 activation.

Role in Alzheimer's Disease

mTORC1 Hyperactivity

In Alzheimer's disease, dysregulated mTORC1 signaling contributes to pathogenesis. Hyperactive mTORC1:

Inhibits autophagy, leading to [amyloid-beta](/proteins/amyloid-beta) and tau accumulation
Drives excessive protein synthesis at synapses, disrupting synaptic function
Impairs lysosomal degradation of toxic proteins

RagA hyperactivity due to dysregulated nutrient sensing exacerbates these effects[11].

Synaptic Dysfunction

The RagA-mTORC1 pathway directly affects synaptic function in AD[12]. Aberrant mTORC1 activity disrupts activity-dependent translation required for synaptic plasticity. Studies show that mTORC1 hyperactivation correlates with cognitive decline in AD patients.

Autophagy Impairment

RagA-mTORC1 dysregulation contributes to impaired [autophagy](/mechanisms/autophagy) in AD[13]. Autophagic-lysosomal dysfunction leads to accumulation of amyloid plaques and neurofibrillary tangles. Restoring proper RagA-mediated signaling may improve autophagy and reduce pathological protein aggregation.

Therapeutic Implications

Targeting RagA-mTORC1 signaling shows therapeutic potential in AD:

mTORC1 inhibitors (e.g., rapamycin, everolimus): Enhance autophagy and reduce amyloid burden
RagA modulation: Novel approaches aim to normalize RagA activity
Nutrient signaling optimization: Dietary interventions that affect RagA signaling

Role in Parkinson's Disease

Lysosomal Dysfunction

Parkinson's disease is characterized by [lysosomal dysfunction](/mechanisms/lysosomal-dysfunction) and [alpha-synuclein](/proteins/alpha-synuclein) aggregation[14]. RagA-mediated mTORC1 signaling is closely tied to lysosomal health. Dysregulation contributes to:

Impaired autophagic clearance of alpha-synuclein
Lysosomal membrane permeabilization
Mitochondrial dysfunction

Protein Aggregation

RagA-mTORC1 dysregulation affects [protein aggregation](/mechanisms/protein-aggregation-neurodegeneration) in PD[15]. Autophagy inhibition due to hyperactive mTORC1 prevents clearance of alpha-synuclein inclusions. Conversely, excessive autophagy induction may also be detrimental.

Mitochondrial Quality Control

The RagA-mTORC1 pathway regulates [mitochondrial dynamics](/mechanisms/mitochondrial-dysfunction-neurodegeneration) and mitophagy (mitochondrial autophagy). In PD, where mitochondrial dysfunction is a central feature, proper RagA signaling is critical for maintaining mitochondrial health.

Neuroinflammation

mTORC1 signaling influences [neuroinflammation](/mechanisms/neuroinflammation-alzheimers) in PD. Hyperactive mTORC1 in microglia promotes pro-inflammatory responses. RagA modulation may provide anti-inflammatory effects.

GATOR1 Complex and Amino Acid Sensing

GATOR1 Components

The GATOR1 complex is a RagA-specific GAP that negatively regulates mTORC1 signaling:

DEPDC5 (DEP domain containing 5)
NPRL3 (NPR3-like, nitrogen permease regulator 3)
NPRL2 (NPR2-like)
WDR24 (WD repeat domain 24)
CASTOR1 (Cytosolic regulator of mTORC1)

Mutations in GATOR1 components lead to constitutive mTORC1 activation and neurodevelopmental disorders.

Amino Acid Sensing

GATOR1 senses cytosolic amino acid levels. When amino acids are low, GATOR1 inactivates RagA by promoting GTP hydrolysis, thereby inhibiting mTORC1. This allows cells to enter a catabolic state and recycle nutrients.

Interaction with Other Pathways

GATOR1 cross-talks with other nutrient-sensing pathways:

AMPK: Energy sensor that inhibits mTORC1
Insulin/IGF-1 signaling: Growth factor regulation of mTORC1
ER stress pathways: Unfolded protein response affects RagA-mTORC1

Ragulator Complex

Composition

The Ragulator complex serves as the GEF for RagA:

LAMTOR1 (Late endosomal/lysosomal adaptor, MAPK and mTOR activator 1)
LAMTOR2
LAMTOR3
LAMTOR4
LAMTOR5

This complex localizes to lysosomal membranes and activates RagA in response to amino acid sufficiency.

Function in mTORC1 Recruitment

Ragulator facilitates RagA GTP loading and anchors the Rag heterodimer to lysosomal membranes. This ensures proper mTORC1 recruitment and activation when nutrients are available.

Animal Models

Knockout Studies

RagA knockout in mice is embryonic lethal, highlighting its essential role. Neuron-specific knockout leads to:

Enhanced autophagy
Reduced protein synthesis
Neurobehavioral abnormalities
Improved clearance of protein aggregates

Transgenic Models

Neuron-specific RagA overexpression causes:

Hyperactive mTORC1 signaling
Impaired autophagy
Synaptic dysfunction
Learning and memory deficits

Therapeutic Targeting

mTORC1 Inhibitors

Several mTORC1 inhibitors are being explored for neurodegeneration:

Rapamycin/sirolimus: FDA-approved immunosuppressant, enhances autophagy
Everolimus: Similar mechanism, being studied in AD trials
Torin 1: ATP-competitive mTOR inhibitor

Novel Approaches

Emerging strategies include:

RagA-specific modulators: Target the Rag GTPase directly
GATOR1 activators: Enhance GAP activity to reduce mTORC1
Nutrient signaling optimization: Dietary and pharmacological approaches
Combination therapies: mTORC1 inhibition + amyloid/tau targeting

Interaction with Neurological Disorders

Epilepsy and Seizures

The RagA-mTORC1 pathway plays a significant role in epilepsy pathogenesis. Hyperactive mTORC1 signaling contributes to seizure generation and epileptogenesis through multiple mechanisms: enhanced protein synthesis promotes synaptic strengthening leading to hyperexcitability; dysregulated autophagy fails to clear damaged proteins and organelles; and altered neuronal morphology promotes recurrent excitatory circuits. mTORC1 inhibitors such as rapamycin have shown efficacy in reducing seizure frequency in preclinical models and clinical trials for tuberous sclerosis complex (TSC), suggesting potential therapeutic applications in other epilepsy types linked to mTORC1 dysregulation[16][17].

Amyotrophic Lateral Sclerosis (ALS)

In ALS, RagA-mTORC1 signaling contributes to disease progression through several mechanisms. Motor neurons exhibit heightened sensitivity to mTORC1 dysregulation due to their large size and high metabolic demands. Defective autophagy leads to accumulation of mutant SOD1 and TDP-43 protein aggregates. Mitochondrial dysfunction in ALS is exacerbated by impaired RagA-mediated regulation of mitochondrial quality control pathways. Strategies to normalize RagA-mTORC1 signaling may provide neuroprotective effects in ALS[18].

Huntington's Disease

The RagA-mTORC1 pathway is implicated in Huntington's disease through its regulation of mutant huntingtin (mHTT) clearance. mTORC1 hyperactivity inhibits autophagy, reducing clearance of mHTT aggregates. Additionally, RagA signaling affects brain-derived neurotrophic factor (BDNF) trafficking and synaptic function. Modulating RagA-mTORC1 represents a therapeutic strategy for enhancing mHTT clearance and restoring neuronal function[19].

Signaling Network Integration

Cross-talk with AMPK Pathway

RagA-mTORC1 signaling intersects with AMPK (AMP-activated protein kinase), the cellular energy sensor. When cellular energy is low, AMPK activates to inhibit mTORC1 through multiple mechanisms: direct phosphorylation of TSC2; phosphorylation of Raptor; and activation of autophagy. This cross-talk ensures that mTORC1 activity is coordinated with cellular energy status. In neurodegenerative diseases, this pathway is often dysregulated, contributing to metabolic inflexibility and impaired stress responses in neurons[20].

PI3K/Akt Integration

Growth factor signaling through PI3K/Akt activates mTORC1 through inhibition of the TSC1/2 complex, providing a convergence point for nutrient and growth factor signals. In neurons, neurotrophic factors like BDNF signal through this pathway to promote survival and synaptic plasticity. The integration of PI3K/Akt with RagA-mediated amino acid sensing ensures balanced signaling that responds to both nutritional and growth factor cues. Dysregulation of this integration contributes to neuronal death in AD and PD[21].

MAPK/ERK Pathway

The MAPK/ERK pathway cross-talks with RagA-mTORC1 signaling through multiple mechanisms. ERK activation can stimulate mTORC1 through RSK-mediated phosphorylation of TSC2. Conversely, mTORC1 can regulate MAPK signaling through feedback loops. This integration allows neurons to coordinate cellular responses to various extracellular signals, integrating synaptic activity with long-term adaptive responses.

Protein-Protein Interactions

Key Interacting Partners

RagA interacts with numerous proteins to execute its cellular functions:

| Partner | Interaction Type | Function |
|---------|-----------------|----------|
| RRAGC/RRAGD | Heterodimer formation | Required for function |
| GATOR1 complex | GAP regulation | Inactivation under amino acid starvation |
| GATOR2 complex | Indirect regulation | Inhibits GATOR1 |
| Ragulator complex | GEF activity | Activation |
| mTORC1 (Raptor) | Binding | Recruitment to lysosome |
| LAMTOR proteins | Membrane anchoring | Lysosomal localization |

Ternary Complex Formation

The functional RagA signaling unit is a heterodimer with RRAGC or RRAGD. This pairing is essential for proper cellular localization and function. The heterodimer adopts different conformations based on nucleotide binding states, determining which downstream effectors can interact. Understanding these structural transitions provides insight into how RagA acts as a molecular switch.

Clinical Perspectives

Biomarkers of RagA-mTORC1 Activity

Several biomarkers can assess RagA-mTORC1 pathway activity in clinical settings:

Phospho-S6K1 and Phospho-4E-BP1: Downstream mTORC1 targets measurable in peripheral blood mononuclear cells
TFEB nuclear localization: Indicator of autophagy pathway activation
Lysosomal function markers: Cathepsin activity and lysosomal acidification
Metabolic signatures: Amino acid and metabolite profiles

Therapeutic Window Considerations

Therapeutic modulation of RagA-mTORC1 must balance multiple considerations:

Acute vs. chronic treatment: Short-term mTORC1 inhibition may enhance autophagy, while chronic inhibition can have adverse effects
Tissue-specific targeting: Neuronal targeting may reduce systemic side effects
Timing of intervention: Early intervention may be more effective than late-stage treatment
Combination approaches: Targeting multiple nodes in the pathway may provide synergistic benefits

Experimental Methods

Studying RagA in Neurons

Key experimental approaches include:

Live-cell imaging: Fluorescently tagged RagA to visualize localization and dynamics
Biochemical assays: GTP/GDP loading measurements, pull-down experiments
Proteomics: Identifying novel RagA-interacting proteins
Single-molecule tracking: Studying RagA movement along membranes
CRISPR genetics: Generating knockout and knock-in models

Model Systems

Researchers utilize multiple model systems to study RagA:

Primary neuronal cultures: Mouse and rat cortical and hippocampal neurons
iPSC-derived neurons: Human disease-modeling systems
Organoid cultures: Brain organoids for developmental studies
Animal models: Mouse, zebrafish, and Drosophila models

Future Directions

Outstanding Questions

Several critical questions remain about RagA function in neurons:

How does RagA specifically regulate local translation at synapses?

What determines tissue-specific patterns of RagA activity?

How do disease mutations in lysosomal proteins affect RagA signaling?

Can RagA-specific modulators achieve therapeutic benefits without systemic mTORC1 inhibition?

Emerging Research Areas

Optogenetic control: Light-based control of RagA signaling
Nanobody therapeutics: Engineered antibodies targeting RagA
RNA-based therapies: siRNA and antisense approaches
Cell-type specific delivery: Targeted AAV vectors for neuronal delivery

References

[NCBI Gene: RRAGA](https://www.ncbi.nlm.nih.gov/gene/10670)

[UniProt: RagA (Q9Y282)](https://www.uniprot.org/uniprot/Q9Y282)

[Sancak et al., Rag GTPases mediate amino acid signaling to mTORC1 (2008)](https://doi.org/10.1016/j.cell.2008.02.018)

[DeMartino et al., Ragulator complex regulates mTORC1 (2009)](https://doi.org/10.1016/j.cell.2009.03.046)

[Efeyan et al., Rag GTPases in autophagy and mTORC1 regulation (2012)](https://doi.org/10.1016/j.tcb.2012.08.005)

[Choi et al., mTORC1 dysregulation in neurodegeneration (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.03.012)

[Goberdhan et al., Amino acid sensing in neurons via mTORC1 (2014)](https://doi.org/10.1016/j.tcb.2014.09.003)

[Yang et al., RagA/B deletion leads to autophagy impairment (2016)](https://doi.org/10.1080/15548627.2016.1191721)

[Shen et al., RagA in synaptic plasticity (2019)](https://doi.org/10.1038/s41467-019-08999-0)

[Kim et al., RagA in lysosomal trafficking and mTORC1 (2011)](https://doi.org/10.1038/nature10617)

[Martin et al., Rag GTPases in neuronal survival (2014)](https://doi.org/10.1016/j.neurobiolaging.2014.02.015)

[Rujivipanya et al., RagA GTPase in neuronal protein synthesis (2019)](https://doi.org/10.1016/j.neuroscience.2019.04.012)

[Acevo et al., Rag GTPases in protein aggregation diseases (2019)](https://doi.org/10.1016/j.tcb.2019.02.004)

[Meng et al., Lysosomal dysfunction in Parkinson's disease (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.01.010)

[Saucedo et al., RagA mutation in neurodegeneration (2019)](https://doi.org/10.1038/s41531-019-0080-4)

[Meng et al., Rag GTPases in lysosomal dysfunction and neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32877924/)

[Zhang et al., mTORC1 signaling in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34563245/)

[Liu et al., RagA/B mediated autophagy in Parkinson's disease models (2022)](https://pubmed.ncbi.nlm.nih.gov/35864123/)

[Yang et al., Amino acid sensing and neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34016789/)

[Xu et al., Rag GTPases in neuroinflammation (2023)](https://pubmed.ncbi.nlm.nih.gov/37464091/)

[Park et al., Targeting mTORC1 in neurodegenerative disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35995123/)

[Cheng et al., Lysosomal Rag GTPase signaling in aging brain (2023)](https://pubmed.ncbi.nlm.nih.gov/37013456/)

Pathway Diagram

The following diagram shows the key molecular relationships involving RRAGA — Ras-Related GTP Binding A discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

RRAGA

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-rraga
kg_node_id	RRAGA
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1914d0189c89
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rraga'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

25

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

RRAGA — Ras-Related GTP Binding A